申请人:Newron Pharmaceuticals S.p.A.
公开号:US07855227B2
公开(公告)日:2010-12-21
2-Phenylethylamino substituted carboxamide derivatives of formula (I); wherein J, W, R0, R1, R2, R3, and R4 have the meanings as defined in the specification and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them as active ingredient and their use as sodium and/or calcium channel modulators useful in preventing alleviating and curing a wide range of pathologies, including neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urology, and gastrointestinal diseases where the above mechanisms have been described as playing a pathological role, are described.
本文描述了公式(I)的2-苯乙基氨基取代的羧酰胺衍生物,其中J、W、R0、R1、R2、R3和R4的含义如规范中所定义,以及其药学上可接受的盐,包含它们作为活性成分的制药组合物,以及它们作为钠和/或钙通道调节剂的用途,用于预防、缓解和治愈广泛的病理学,包括神经、精神、心血管、炎症、眼科、泌尿科和胃肠疾病,在这些病理学中上述机制被描述为发挥病理作用。